BioVie Inc. - Common stock (BIVI)
1.1000
+0.0200 (1.85%)
Biovie Inc is a biotechnology company focused on developing innovative therapeutic solutions for neurological and psychiatric disorders
The company is dedicated to advancing its proprietary drug candidates through rigorous clinical research, aiming to address unmet medical needs in these fields. By leveraging cutting-edge science and technology, Biovie Inc seeks to improve treatment options and outcomes for patients suffering from various conditions, demonstrating a commitment to enhancing quality of life through effective healthcare solutions.
